Abbvie Inc (ABBV)

$211.32 +7.43 (3.64%)
Market Cap 360.51B
Revenue (ttm) 61.16B
Net Income (ttm) 4.23B
EPS (ttm) N/A
PE Ratio 19.77
Forward PE 13.92
Profit Margin 6.91%
Debt to Equity Ratio -20.91
Volume 10,319,200
Avg Vol 7,028,170
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 85%
Beta 0.38
Analysts Strong Sell
Price Target $249.93

Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 847 932 7900
Address:
1 North Waukegan Road, North Chicago, United States
AirForce1000
AirForce1000 May. 1 at 8:49 AM
$ABBV https://www.knicksnewyork.com LFG
0 · Reply
Maxwell_Osgood
Maxwell_Osgood May. 1 at 12:33 AM
$ABBV
0 · Reply
VeltrixCapitalOfficial
VeltrixCapitalOfficial Apr. 30 at 11:39 PM
I AM THE BEST TRADER ON THIS SPACE🏆 $FDX 1,750%✅ $ABBV 1560% ✅ $AMZN 1,520% ✅ $AAPL 1,300%✅ $IBM 1,250%✅ $AAPL 1,200% ✅ OTHER TRADES POSTED ON TELEGRAM LINK IN BIO
1 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 30 at 10:11 PM
$SLS $ABBV $BMY $RRHBY Own Aza VEN - they Know PRECISELY how these drugs perform in AML Remission. - They've conducted many trials, including the VIALE-M and T P3's that Recently Failed. - if AzaVEN achieved the Durable OS we are seeing Now in the REGLA trial, VIALE-M Would NOT have been Terminated. MOST IMPORTANTLY - SLS Market Value Would NOT Have Increased 1,000% Since the IDMC Unblinded Actual MOS and IR Interim Data from the Ongoing P3 - They Know Precisely that its GPS
1 · Reply
GokuStocks_
GokuStocks_ Apr. 30 at 8:36 PM
Have you missed AKAN & RDAC?? Are you tired of being late and chasing?? Then make sure to put ticker RYOJ onto your watchlist. RYOJ is a new IPO ticker with only about 200 watchers on Stocktwits and recent great news. RYOJ is completely under the radar. It can from 2$ to +10$ before. I took a heavy position and looking for a big profit short term. You do you. $CCJ $SES $FSLR $ABBV Watchlist))
0 · Reply
Donib11
Donib11 Apr. 30 at 8:02 PM
$ABBV not as strong of a close as I wanted, but still a nice Green Day! Let’s see 215+ tmrw 🥂
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 30 at 7:57 PM
$SLS +/- 60 Events for the Control Arm While we Await 80 Gps Phase 3 MOS is > 30 Months and Not Yet Reached. For the Short BUS Crew Aza+VEN, BAT / Best Available Treatment for REGAL P3 CONTROL ARM patients Recently FAILED 3 Large Phase 3 Trials - since August 2025, 3 P3 AZA VEN Trials Conducted by $ABBV Failed. - its Gps Immunotherapy doing what its always done, BAT - Failed... - VERONA Failed to show OS benefit - VIALE-T FAILED for aml transplant maintenance - VIALE-M FAILED for AML CR1 Remission Maintenance FAILED - 7 DIFFERENT DOSING COHORTS - all Oral, all combo's FAILED. BAT FAILED - its Gps causing the Near Miraculous survival.
0 · Reply
focafoca99
focafoca99 Apr. 30 at 7:50 PM
$ABBV honored RIME Therapeutics with its Quebec biotech innovators award in partnership with adMare BioInnovations. https://www.rapidticker.com/news/abbv-abbvie-et-admare-bioinnovations-nomment-5c77ab
0 · Reply
Donib11
Donib11 Apr. 30 at 7:10 PM
$ABBV great start to power hour boys and gals! Keep it going, SHOW ME 215
0 · Reply
Donib11
Donib11 Apr. 30 at 6:35 PM
$ABBV pls explode during power hour 🙏
0 · Reply
Latest News on ABBV
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec

Apr 30, 2026, 3:00 PM EDT - 14 hours ago

AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec

Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month

Apr 30, 2026, 9:00 AM EDT - 20 hours ago

Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month

AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience Strength

Apr 29, 2026, 2:49 PM EDT - 1 day ago

AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience Strength

AbbVie Earnings Call Transcript: Q1 2026

Apr 29, 2026, 9:00 AM EDT - 1 day ago

AbbVie Earnings Call Transcript: Q1 2026

AbbVie Raises FY Guidance on Immunology, Neuroscience Growth

Apr 29, 2026, 8:32 AM EDT - 1 day ago

AbbVie Raises FY Guidance on Immunology, Neuroscience Growth

AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline

Apr 29, 2026, 7:50 AM EDT - 1 day ago

AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline

AbbVie Reports First-Quarter 2026 Financial Results

Apr 29, 2026, 7:47 AM EDT - 1 day ago

AbbVie Reports First-Quarter 2026 Financial Results

AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata

Apr 28, 2026, 8:00 AM EDT - 2 days ago

AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata

EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie

Apr 28, 2026, 7:00 AM EDT - 2 days ago

EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie

AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

Apr 27, 2026, 8:05 AM EDT - 3 days ago

AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

US FDA declines to approve AbbVie's wrinkle treatment

Apr 23, 2026, 4:19 PM EDT - 7 days ago

US FDA declines to approve AbbVie's wrinkle treatment

AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.

Apr 23, 2026, 4:05 PM EDT - 7 days ago

AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.

AbbVie to build $1.4 billion manufacturing campus in North Carolina

Apr 22, 2026, 12:59 PM EDT - 8 days ago

AbbVie to build $1.4 billion manufacturing campus in North Carolina

AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus

Apr 22, 2026, 12:02 PM EDT - 8 days ago

AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

Apr 20, 2026, 2:30 AM EDT - 11 days ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

Apr 15, 2026, 8:16 AM EDT - 15 days ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

MDT

Erin Lichy Gets Real About Her Natrelle® Breast Augmentation

Apr 14, 2026, 8:50 AM EDT - 16 days ago

Erin Lichy Gets Real About Her Natrelle® Breast Augmentation

Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

Apr 13, 2026, 2:24 AM EDT - 18 days ago

Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026

Apr 12, 2026, 7:15 AM EDT - 18 days ago

AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026

AbbVie files lawsuit to address 'outdated' drug discount eligibility program

Apr 8, 2026, 1:38 PM EDT - 22 days ago

AbbVie files lawsuit to address 'outdated' drug discount eligibility program

BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year

Apr 8, 2026, 8:00 AM EDT - 22 days ago

BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year

The price Americans pay for medicine has gotten horribly out of control. Here's how to fix it.

Apr 7, 2026, 9:53 AM EDT - 23 days ago

The price Americans pay for medicine has gotten horribly out of control. Here's how to fix it.

Allergan Aesthetics Third State-of-the-Art AMI Center Opens in Austin

Apr 7, 2026, 9:00 AM EDT - 23 days ago

Allergan Aesthetics Third State-of-the-Art AMI Center Opens in Austin

Swiss industry body says US tariffs on pharmaceuticals will harm patients

Apr 3, 2026, 11:08 AM EDT - 27 days ago

Swiss industry body says US tariffs on pharmaceuticals will harm patients

AMGN AZN BMY MRK NVO

Trump Administration Unveils Up to 100% Tariff on Branded Drugs

Apr 2, 2026, 5:34 PM EDT - 4 weeks ago

Trump Administration Unveils Up to 100% Tariff on Branded Drugs

AZN NVO AMGN BMY MRK

Trump threatens 100% tariff on US drug makers that don't strike deals to lower prices

Apr 2, 2026, 5:33 PM EDT - 4 weeks ago

Trump threatens 100% tariff on US drug makers that don't strike deals to lower prices

AMGN AZN BMY MRK NVO

Drugmakers face 100% tariff unless they cut prices or produce drugs in US

Apr 2, 2026, 3:29 PM EDT - 4 weeks ago

Drugmakers face 100% tariff unless they cut prices or produce drugs in US

AZN NVO AMGN BMY MRK

Global pharma companies that have publicly announced Trump drug pricing agreements

Apr 2, 2026, 2:59 PM EDT - 4 weeks ago

Global pharma companies that have publicly announced Trump drug pricing agreements

AMGN AZN BMY MRK

Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®

Mar 31, 2026, 8:05 AM EDT - 4 weeks ago

Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®

AbbVie to Host First-Quarter 2026 Earnings Conference Call

Mar 31, 2026, 8:00 AM EDT - 4 weeks ago

AbbVie to Host First-Quarter 2026 Earnings Conference Call

AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

Mar 27, 2026, 10:00 AM EDT - 4 weeks ago

AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

AbbVie Named Official Pharmaceutical Partner of Major League Baseball

Mar 24, 2026, 8:00 AM EDT - 5 weeks ago

AbbVie Named Official Pharmaceutical Partner of Major League Baseball

US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings

Mar 20, 2026, 12:11 PM EDT - 5 weeks ago

US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings

AMRX NVS OGN

Buy Or Fear AbbVie Stock At $210?

Mar 19, 2026, 9:26 AM EDT - 6 weeks ago

Buy Or Fear AbbVie Stock At $210?

Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions

Mar 19, 2026, 3:00 AM EDT - 6 weeks ago

Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 6 weeks ago

TrumpRx lists many medicines at prices higher than paid in UK

AMGN AZN BMY GILD GSK JNJ LLY

Big drugmakers must face US overcharge claims on medications for low-income patients

Mar 17, 2026, 2:32 PM EDT - 6 weeks ago

Big drugmakers must face US overcharge claims on medications for low-income patients

AZN NVS SNY

New York Plastic Surgical Group and Deep Blue Med Spa Named #1 in New York by Allergan Aesthetics for the Second Year in a Row

Mar 13, 2026, 9:00 AM EDT - 6 weeks ago

New York Plastic Surgical Group and Deep Blue Med Spa Named #1 in New York by Allergan Aesthetics for the Second Year in a Row

AbbVie Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 11:20 AM EDT - 7 weeks ago

AbbVie Transcript: Leerink Global Healthcare Conference 2026

AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults

Mar 9, 2026, 8:00 AM EDT - 7 weeks ago

AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults

AbbVie Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 11:10 AM EST - 2 months ago

AbbVie Transcript: TD Cowen 46th Annual Health Care Conference

AbbVie to Present at the Leerink Partners Global Healthcare Conference

Mar 3, 2026, 8:00 AM EST - 2 months ago

AbbVie to Present at the Leerink Partners Global Healthcare Conference

AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease

Mar 2, 2026, 8:30 AM EST - 2 months ago

AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease

AbbVie to Present at the TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 8:00 AM EST - 2 months ago

AbbVie to Present at the TD Cowen 46th Annual Health Care Conference

AbbVie to invest $380 million to expand US manufacturing in Illinois

Feb 23, 2026, 12:03 PM EST - 2 months ago

AbbVie to invest $380 million to expand US manufacturing in Illinois

AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States

Feb 23, 2026, 11:00 AM EST - 2 months ago

AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States

U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)

Feb 20, 2026, 2:00 AM EST - 2 months ago

U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)

AbbVie Declares Quarterly Dividend

Feb 19, 2026, 9:37 AM EST - 2 months ago

AbbVie Declares Quarterly Dividend

AbbVie Transcript: Piper Sandler Virtual Novel Targets in Immunology Symposium

Feb 13, 2026, 10:00 AM EST - 2 months ago

AbbVie Transcript: Piper Sandler Virtual Novel Targets in Immunology Symposium

AbbVie sues US health agency over Botox price controls

Feb 11, 2026, 6:49 PM EST - 2 months ago

AbbVie sues US health agency over Botox price controls

Abbvie sues US health agency over Botox

Feb 11, 2026, 5:13 PM EST - 2 months ago

Abbvie sues US health agency over Botox

AbbVie's Inflammation Drug Humira Slows, But Skyrizi, Rinvoq Drive Revenue Growth

Feb 4, 2026, 12:38 PM EST - 3 months ago

AbbVie's Inflammation Drug Humira Slows, But Skyrizi, Rinvoq Drive Revenue Growth

AbbVie Earnings Call Transcript: Q4 2025

Feb 4, 2026, 9:00 AM EST - 3 months ago

AbbVie Earnings Call Transcript: Q4 2025

AbbVie Revenue Rises on Immunology Growth

Feb 4, 2026, 8:34 AM EST - 3 months ago

AbbVie Revenue Rises on Immunology Growth

AbbVie Earnings Beat Wall Street Expectations. The Stock Is Falling Anyway.

Feb 4, 2026, 8:18 AM EST - 3 months ago

AbbVie Earnings Beat Wall Street Expectations. The Stock Is Falling Anyway.

AbbVie Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 11:15 AM EST - 3 months ago

AbbVie Transcript: 44th Annual J.P. Morgan Healthcare Conference

AbbVie Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 8:30 AM EST - 5 months ago

AbbVie Transcript: Piper Sandler 37th Annual Healthcare Conference

AbbVie Transcript: 7th Annual Healthcare Symposium

Nov 14, 2025, 11:55 AM EST - 5 months ago

AbbVie Transcript: 7th Annual Healthcare Symposium

AbbVie Earnings Call Transcript: Q3 2025

Oct 31, 2025, 9:00 AM EDT - 6 months ago

AbbVie Earnings Call Transcript: Q3 2025

AbbVie Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 10:00 AM EDT - 8 months ago

AbbVie Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

AbbVie Earnings Call Transcript: Q2 2025

Jul 31, 2025, 9:00 AM EDT - 9 months ago

AbbVie Earnings Call Transcript: Q2 2025

AbbVie Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 10, 2025, 11:20 AM EDT - 11 months ago

AbbVie Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

AbbVie Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 1:00 PM EDT - 1 year ago

AbbVie Transcript: BofA Securities 2025 Healthcare Conference

AbbVie Transcript: AGM 2025

May 9, 2025, 10:00 AM EDT - 1 year ago

AbbVie Transcript: AGM 2025

AbbVie Earnings Call Transcript: Q1 2025

Apr 25, 2025, 9:00 AM EDT - 1 year ago

AbbVie Earnings Call Transcript: Q1 2025

AbbVie Transcript: Leerink’s Global Healthcare Conference 2025

Mar 11, 2025, 8:40 AM EDT - 1 year ago

AbbVie Transcript: Leerink’s Global Healthcare Conference 2025

AbbVie Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 5, 2025, 9:10 AM EST - 1 year ago

AbbVie Transcript: TD Cowen 45th Annual Healthcare Conference

AbbVie Earnings Call Transcript: Q4 2024

Jan 31, 2025, 9:00 AM EST - 1 year ago

AbbVie Earnings Call Transcript: Q4 2024

AbbVie Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 11:15 AM EST - 1 year ago

AbbVie Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

AbbVie Transcript: Citi's 2024 Global Healthcare Conference

Dec 3, 2024, 10:15 AM EST - 1 year ago

AbbVie Transcript: Citi's 2024 Global Healthcare Conference

AbbVie Earnings Call Transcript: Q3 2024

Oct 30, 2024, 9:00 AM EDT - 1 year ago

AbbVie Earnings Call Transcript: Q3 2024

AbbVie Earnings Call Transcript: Q2 2024

Jul 25, 2024, 9:00 AM EDT - 1 year ago

AbbVie Earnings Call Transcript: Q2 2024

AbbVie Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Jun 12, 2024, 10:00 AM EDT - 2 years ago

AbbVie Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

AbbVie Transcript: BofA Securities 2024 Health Care Conference

May 15, 2024, 1:40 PM EDT - 2 years ago

AbbVie Transcript: BofA Securities 2024 Health Care Conference

AbbVie Transcript: ASM 2024

May 3, 2024, 10:00 AM EDT - 2 years ago

AbbVie Transcript: ASM 2024

AbbVie Earnings Call Transcript: Q1 2024

Apr 26, 2024, 9:00 AM EDT - 2 years ago

AbbVie Earnings Call Transcript: Q1 2024

AbbVie Transcript: Barclays 26th Annual Global Healthcare Conference 2024

Mar 14, 2024, 9:00 AM EDT - 2 years ago

AbbVie Transcript: Barclays 26th Annual Global Healthcare Conference 2024

AbbVie Transcript: TD Cowen 44th Annual Health Care Conference 2024

Mar 5, 2024, 9:10 AM EST - 2 years ago

AbbVie Transcript: TD Cowen 44th Annual Health Care Conference 2024

AbbVie Earnings Call Transcript: Q4 2023

Feb 2, 2024, 9:00 AM EST - 2 years ago

AbbVie Earnings Call Transcript: Q4 2023

AbbVie Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 10, 2024, 11:15 AM EST - 2 years ago

AbbVie Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

AbbVie Transcript: M&A Announcement

Dec 7, 2023, 9:00 AM EST - 2 years ago

AbbVie Transcript: M&A Announcement

AbbVie Transcript: M&A Announcement

Nov 30, 2023, 9:00 AM EST - 2 years ago

AbbVie Transcript: M&A Announcement

AbbVie Earnings Call Transcript: Q3 2023

Oct 27, 2023, 9:00 AM EDT - 2 years ago

AbbVie Earnings Call Transcript: Q3 2023

AbbVie Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Sep 13, 2023, 10:50 AM EDT - 2 years ago

AbbVie Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

AbbVie Earnings Call Transcript: Q2 2023

Jul 27, 2023, 9:00 AM EDT - 3 years ago

AbbVie Earnings Call Transcript: Q2 2023

AbbVie Transcript: Bank of America Global Healthcare Conference

May 9, 2023, 11:00 AM EDT - 3 years ago

AbbVie Transcript: Bank of America Global Healthcare Conference

AbbVie Earnings Call Transcript: Q1 2023

Apr 27, 2023, 9:00 AM EDT - 3 years ago

AbbVie Earnings Call Transcript: Q1 2023

AbbVie Transcript: Barclays Global Healthcare Conference

Mar 15, 2023, 1:35 PM EDT - 3 years ago

AbbVie Transcript: Barclays Global Healthcare Conference

AbbVie Transcript: Cowen Health Care Conference

Mar 7, 2023, 9:10 AM EST - 3 years ago

AbbVie Transcript: Cowen Health Care Conference

AbbVie Earnings Call Transcript: Q4 2022

Feb 9, 2023, 9:00 AM EST - 3 years ago

AbbVie Earnings Call Transcript: Q4 2022

AbbVie Transcript: JPMorgan Healthcare Conference

Jan 10, 2023, 6:00 PM EST - 3 years ago

AbbVie Transcript: JPMorgan Healthcare Conference

AbbVie Earnings Call Transcript: Q3 2022

Oct 28, 2022, 9:00 AM EDT - 3 years ago

AbbVie Earnings Call Transcript: Q3 2022

AbbVie Earnings Call Transcript: Q2 2022

Jul 29, 2022, 6:27 AM EDT - 4 years ago

AbbVie Earnings Call Transcript: Q2 2022

AbbVie Earnings Call Transcript: Q1 2022

Apr 29, 2022, 12:59 PM EDT - 4 years ago

AbbVie Earnings Call Transcript: Q1 2022

AbbVie Earnings Call Transcript: Q4 2021

Feb 2, 2022, 2:50 PM EST - 4 years ago

AbbVie Earnings Call Transcript: Q4 2021

AbbVie Transcript: J.P. Morgan Healthcare Conference

Jan 11, 2022, 5:44 AM EST - 4 years ago

AbbVie Transcript: J.P. Morgan Healthcare Conference

AbbVie Earnings Call Transcript: Q3 2021

Oct 28, 2021, 8:00 PM EDT - 4 years ago

AbbVie Earnings Call Transcript: Q3 2021

AbbVie Earnings Call Transcript: Q2 2021

Jul 29, 2021, 8:20 PM EDT - 5 years ago

AbbVie Earnings Call Transcript: Q2 2021

AbbVie Transcript: ASM 2021

May 7, 2021, 5:53 AM EDT - 5 years ago

AbbVie Transcript: ASM 2021

AbbVie Earnings Call Transcript: Q1 2021

Apr 30, 2021, 8:42 AM EDT - 5 years ago

AbbVie Earnings Call Transcript: Q1 2021

AbbVie Earnings Call Transcript: Q4 2020

Feb 3, 2021, 9:00 AM EST - 5 years ago

AbbVie Earnings Call Transcript: Q4 2020

AbbVie Transcript: Strategy Update

Dec 14, 2020, 10:00 AM EST - 5 years ago

AbbVie Transcript: Strategy Update

AbbVie Earnings Call Transcript: Q3 2020

Oct 30, 2020, 9:00 AM EDT - 5 years ago

AbbVie Earnings Call Transcript: Q3 2020

AbbVie Earnings Call Transcript: Q2 2020

Jul 31, 2020, 9:00 AM EDT - 6 years ago

AbbVie Earnings Call Transcript: Q2 2020

AbbVie Transcript: ASM 2020

May 8, 2020, 10:00 AM EDT - 6 years ago

AbbVie Transcript: ASM 2020

AbbVie Earnings Call Transcript: Q1 2020

May 1, 2020, 9:00 AM EDT - 6 years ago

AbbVie Earnings Call Transcript: Q1 2020

AbbVie Earnings Call Transcript: Q4 2019

Feb 7, 2020, 9:00 AM EST - 6 years ago

AbbVie Earnings Call Transcript: Q4 2019

AbbVie Earnings Call Transcript: Q3 2019

Nov 1, 2019, 9:00 AM EDT - 7 years ago

AbbVie Earnings Call Transcript: Q3 2019

AbbVie Earnings Call Transcript: Q2 2019

Jul 26, 2019, 9:00 AM EDT - 7 years ago

AbbVie Earnings Call Transcript: Q2 2019

AbbVie Transcript: M&A Announcement

Jun 25, 2019, 8:30 AM EDT - 7 years ago

AbbVie Transcript: M&A Announcement

AbbVie Earnings Call Transcript: Q1 2019

Apr 25, 2019, 9:00 AM EDT - 7 years ago

AbbVie Earnings Call Transcript: Q1 2019

AbbVie Earnings Call Transcript: Q4 2018

Jan 25, 2019, 9:00 AM EST - 7 years ago

AbbVie Earnings Call Transcript: Q4 2018

AbbVie Earnings Call Transcript: Q3 2018

Nov 2, 2018, 9:00 AM EDT - 8 years ago

AbbVie Earnings Call Transcript: Q3 2018

AbbVie Earnings Call Transcript: Q2 2018

Jul 27, 2018, 9:00 AM EDT - 8 years ago

AbbVie Earnings Call Transcript: Q2 2018

AbbVie Earnings Call Transcript: Q1 2018

Apr 26, 2018, 9:00 AM EDT - 8 years ago

AbbVie Earnings Call Transcript: Q1 2018

AbbVie Earnings Call Transcript: Q4 2017

Jan 26, 2018, 9:00 AM EST - 8 years ago

AbbVie Earnings Call Transcript: Q4 2017

AbbVie Earnings Call Transcript: Q3 2017

Oct 27, 2017, 9:00 AM EDT - 9 years ago

AbbVie Earnings Call Transcript: Q3 2017

AbbVie Earnings Call Transcript: Q2 2017

Jul 28, 2017, 9:00 AM EDT - 9 years ago

AbbVie Earnings Call Transcript: Q2 2017

AbbVie Earnings Call Transcript: Q1 2017

Apr 27, 2017, 9:00 AM EDT - 9 years ago

AbbVie Earnings Call Transcript: Q1 2017

AbbVie Earnings Call Transcript: Q4 2016

Jan 27, 2017, 9:00 AM EST - 10 years ago

AbbVie Earnings Call Transcript: Q4 2016

AbbVie Earnings Call Transcript: Q3 2016

Oct 28, 2016, 9:00 AM EDT - 10 years ago

AbbVie Earnings Call Transcript: Q3 2016

AbbVie Earnings Call Transcript: Q2 2016

Jul 29, 2016, 9:00 AM EDT - 10 years ago

AbbVie Earnings Call Transcript: Q2 2016

AbbVie Transcript: R&D Day 2016

Jun 3, 2016, 10:00 AM EDT - 10 years ago

AbbVie Transcript: R&D Day 2016

AbbVie Earnings Call Transcript: Q1 2016

Apr 28, 2016, 9:00 AM EDT - 10 years ago

AbbVie Earnings Call Transcript: Q1 2016

AbbVie Earnings Call Transcript: Q4 2015

Jan 29, 2016, 9:00 AM EST - 11 years ago

AbbVie Earnings Call Transcript: Q4 2015

AbbVie Earnings Call Transcript: Q3 2015

Oct 30, 2015, 10:00 AM EDT - 11 years ago

AbbVie Earnings Call Transcript: Q3 2015

AbbVie Earnings Call Transcript: Q2 2015

Jul 24, 2015, 9:00 AM EDT - 11 years ago

AbbVie Earnings Call Transcript: Q2 2015

AbbVie Earnings Call Transcript: Q1 2015

Apr 23, 2015, 9:00 AM EDT - 11 years ago

AbbVie Earnings Call Transcript: Q1 2015

AbbVie Transcript: M&A Announcement

Mar 5, 2015, 9:00 AM EST - 12 years ago

AbbVie Transcript: M&A Announcement

AbbVie Earnings Call Transcript: Q4 2014

Jan 30, 2015, 9:00 AM EST - 12 years ago

AbbVie Earnings Call Transcript: Q4 2014

AbbVie Earnings Call Transcript: Q3 2014

Oct 31, 2014, 9:00 AM EDT - 12 years ago

AbbVie Earnings Call Transcript: Q3 2014

AbbVie Earnings Call Transcript: Q2 2014

Jul 25, 2014, 9:00 AM EDT - 12 years ago

AbbVie Earnings Call Transcript: Q2 2014

AbbVie Earnings Call Transcript: Q1 2014

Apr 25, 2014, 9:00 AM EDT - 13 years ago

AbbVie Earnings Call Transcript: Q1 2014

AbbVie Earnings Call Transcript: Q4 2013

Jan 31, 2014, 9:00 AM EST - 13 years ago

AbbVie Earnings Call Transcript: Q4 2013

AbbVie Earnings Call Transcript: Q3 2013

Oct 25, 2013, 9:00 AM EDT - 13 years ago

AbbVie Earnings Call Transcript: Q3 2013

AbbVie Earnings Call Transcript: Q2 2013

Jul 26, 2013, 9:00 AM EDT - 13 years ago

AbbVie Earnings Call Transcript: Q2 2013

AbbVie Earnings Call Transcript: Q1 2013

Apr 26, 2013, 9:00 AM EDT - 14 years ago

AbbVie Earnings Call Transcript: Q1 2013

AbbVie Earnings Call Transcript: Q4 2012

Jan 30, 2013, 9:00 AM EST - 14 years ago

AbbVie Earnings Call Transcript: Q4 2012

AirForce1000
AirForce1000 May. 1 at 8:49 AM
$ABBV https://www.knicksnewyork.com LFG
0 · Reply
Maxwell_Osgood
Maxwell_Osgood May. 1 at 12:33 AM
$ABBV
0 · Reply
VeltrixCapitalOfficial
VeltrixCapitalOfficial Apr. 30 at 11:39 PM
I AM THE BEST TRADER ON THIS SPACE🏆 $FDX 1,750%✅ $ABBV 1560% ✅ $AMZN 1,520% ✅ $AAPL 1,300%✅ $IBM 1,250%✅ $AAPL 1,200% ✅ OTHER TRADES POSTED ON TELEGRAM LINK IN BIO
1 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 30 at 10:11 PM
$SLS $ABBV $BMY $RRHBY Own Aza VEN - they Know PRECISELY how these drugs perform in AML Remission. - They've conducted many trials, including the VIALE-M and T P3's that Recently Failed. - if AzaVEN achieved the Durable OS we are seeing Now in the REGLA trial, VIALE-M Would NOT have been Terminated. MOST IMPORTANTLY - SLS Market Value Would NOT Have Increased 1,000% Since the IDMC Unblinded Actual MOS and IR Interim Data from the Ongoing P3 - They Know Precisely that its GPS
1 · Reply
GokuStocks_
GokuStocks_ Apr. 30 at 8:36 PM
Have you missed AKAN & RDAC?? Are you tired of being late and chasing?? Then make sure to put ticker RYOJ onto your watchlist. RYOJ is a new IPO ticker with only about 200 watchers on Stocktwits and recent great news. RYOJ is completely under the radar. It can from 2$ to +10$ before. I took a heavy position and looking for a big profit short term. You do you. $CCJ $SES $FSLR $ABBV Watchlist))
0 · Reply
Donib11
Donib11 Apr. 30 at 8:02 PM
$ABBV not as strong of a close as I wanted, but still a nice Green Day! Let’s see 215+ tmrw 🥂
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 30 at 7:57 PM
$SLS +/- 60 Events for the Control Arm While we Await 80 Gps Phase 3 MOS is > 30 Months and Not Yet Reached. For the Short BUS Crew Aza+VEN, BAT / Best Available Treatment for REGAL P3 CONTROL ARM patients Recently FAILED 3 Large Phase 3 Trials - since August 2025, 3 P3 AZA VEN Trials Conducted by $ABBV Failed. - its Gps Immunotherapy doing what its always done, BAT - Failed... - VERONA Failed to show OS benefit - VIALE-T FAILED for aml transplant maintenance - VIALE-M FAILED for AML CR1 Remission Maintenance FAILED - 7 DIFFERENT DOSING COHORTS - all Oral, all combo's FAILED. BAT FAILED - its Gps causing the Near Miraculous survival.
0 · Reply
focafoca99
focafoca99 Apr. 30 at 7:50 PM
$ABBV honored RIME Therapeutics with its Quebec biotech innovators award in partnership with adMare BioInnovations. https://www.rapidticker.com/news/abbv-abbvie-et-admare-bioinnovations-nomment-5c77ab
0 · Reply
Donib11
Donib11 Apr. 30 at 7:10 PM
$ABBV great start to power hour boys and gals! Keep it going, SHOW ME 215
0 · Reply
Donib11
Donib11 Apr. 30 at 6:35 PM
$ABBV pls explode during power hour 🙏
0 · Reply
DHouston7
DHouston7 Apr. 30 at 6:32 PM
$ABBV love this juggernaut. Goes down, buy. Goes up, buy. Goes sideways, buy. Been in it since 1-1-13 😎
0 · Reply
ksoption
ksoption Apr. 30 at 6:19 PM
$ABBV $TSLA
0 · Reply
NRG8
NRG8 Apr. 30 at 5:19 PM
$JNJ $ABBV $BAC $PG $CVX . ..
0 · Reply
Donib11
Donib11 Apr. 30 at 5:08 PM
$ABBV GIVE ME 215 BABYYYYY
0 · Reply
OptiMusktic
OptiMusktic Apr. 30 at 4:47 PM
$ABBV
0 · Reply
Scanlz
Scanlz Apr. 30 at 4:46 PM
$ABBV Estimated price prediction by 2030 ranges from $275-$320 so even owning below 100 shares will give you a good gain.
0 · Reply
Donib11
Donib11 Apr. 30 at 4:40 PM
$ABBV @jbops3 how are you doing my child? 😂
0 · Reply
CapitalMonk
CapitalMonk Apr. 30 at 4:15 PM
$ABBV Price: $212.40 (+4.18%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.73% RSI: 58.5 | Momentum: Moderate Volume: -40.7% vs avg Volatility: 1.83% Support: $190.75 | Resistance: $214.87 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 30 at 4:14 PM
$META Moved the last shares into $SLS - Phase 3 RESULTs with 10x to 50x ROI Upside are Now Imminent. Immunotherapy for AML Remission Maintenance, seeing extended Near Miraculous All Pooled Survival, and the Best Available Treatment for Control Arm Patients, recently - since Aug 2025 FAILED 3 Large Phase 3 Trials $ABBV for AML Remission Maintenance. no brainer.
0 · Reply
Jblack500
Jblack500 Apr. 30 at 2:41 PM
@MaverikIT @No_Face_character @cynicaloptimist @IsabellaDC @BustaCapital @WAJeff $GILD $ABBV . ABBV bottomed yesterday, if you blinked you missed it
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Apr. 30 at 2:32 PM
$ABBV I guess you are done posting under this handle for the time being.
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 30 at 2:10 PM
$SLS $ABBV
0 · Reply